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species. Drosophila has only two such genes, 14-3-3f (leo), encoding two isoforms LEOI and LEOII,
and 14-3-3e. We report a bona ﬁde third functional isoform encoded by leo divergent from the other
two in structurally and functionally signiﬁcant areas, thus increasing 14-3-3 diversity in Drosophila.
Furthermore, we used a novel approach of spatially restricted leo abrogation by RNA-interference
and revealed differential LEO distribution in adult heads, with LEOIII enrichment in neurons essen-
tial for learning and memory in Drosophila.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The 14-3-3 proteins comprise a family of small acidic molecules
with apparently diverse cellular functions [1,2]. Each 14-3-3 pro-
tein consists of nine anti-parallel a-helices arranged in a character-
istic U shape [1,3]. The four amino-terminal helixes are essential
for dimerization [4] and 14-3-3s form homo and heterodimers
[5]. Multiple family members are present in all eukaryotes exam-
ined [6,7], but the number of 14-3-3 isotypes differs per species.
Animal family members are divided into two conservation groups
based on protein sequence similarity. The typical group contains
the b,c,g, f and a, d which are the phosphorylated forms of b
and f respectively. Members of the typical group share 75–92% se-
quence identity, while e, r and s of the atypical group are more
dissimilar with the typical isotypes, yet 45–63% identical among
them [8]. With the exception of r which is epithelial cell-speciﬁc,
all vertebrate isotypes are primarily expressed in neurons [8,9].
Unlike the seven distinct 14-3-3 genes in mammals, Drosophila
contains two 14-3-3 genes, one from each conservation group
[8,10]. The D14-3-3e gene encodes a single protein, whereas, the
14-3-3f, or leonardo was reported to encode two isoforms LEOI
and LEOII arising by incorporating one of the mutually exclusive
exons 6 and 60 in the mRNA [10–12]. However, the recently anno-chemical Societies. Published by E
lakis).tated Drosophila genome predicted the existence of a third possi-
ble exon 6 (http://ﬂybase.org/reports/FBgn0004907.html),
potentially encoding a third, divergent LEO isoform. Because tis-
sue-speciﬁc functional divergence has been reported for LEOI and
LEOII [11], we tested the prediction of a third functional LEO iso-
form by expression analysis, genetic complementation tests and
tissue speciﬁcity in its distribution.
2. Materials and methods
2.1. Drosophila culture, strains and genetics
Drosophila were cultured as before [11]. The UAS-leoI, and UAS-
leoII transgenes have been described previously [11]. cDNAs for
UAS-leoIIIFlag were obtained from Levitan et al. [13], subcloned
into pUAST, transformants were generated and normalized to the
Cantonised w1188 genetic background [11]. Transgenes on the third
chromosome were used for ease of manipulations and introduced
in the lethal leop1188/CyO or leoP2335/CyO mutant backgrounds
[10]. Two novel insertions in leo carrying the Gal4-encoding
P{GawB} were characterized and obtained from the Japanese Na-
tional Institute of Genetics. The homozygous viable leoNP0863 strain
(leoGal4) and leoNP7346 which is homozygous lethal, neighboring
previously described [14] lethal insertions (Fig. 1A). The leoRNAi
transgenic line was obtained from the Vienna Drosophila Resource
Centre and was normalized to Cantonised w1188. ElavGal4 has been
described previously [15], whereas ElavGal4; leoP1188/CyO waslsevier B.V. All rights reserved.
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leoP2335 homozygous lethality, leoP1188/CyO and leoP2335/CyO trans-
gene-bearing males (i.e. leoP1188/CyO; LEOI, etc.), were crossed en
masse with ElavGal4; leoP1188/CyO virgin females. Control crosses
were w1118 virgin females crossed to the transgene-carrying strain
(leoP1188/CyO; leoI). The proportion of straight-winged progeny
over the total was estimated for each cross.
2.2. Sequence alignments and analysis
leo genomic sequence was obtained from Flybase (http://
www.ﬂybase.org) and GeneDoc (http://www.nrbsc.org/gfx/gene-
doc/index.html) was used for protein sequence alignment. The fol-
lowing FLYBASE identiﬁcation numbers are assigned to the distinct
transcripts:Transcript
typeFLYBASE
transcriptFLYBASE ID# NCBI RefSeqleo I 14-3-3zeta-RD FBtr0088414 NM_057537
14-3-3zeta-RE FBtr0088415 NM_ 165740
14-3-3zeta-RJ FBtr0100183 NM_001014515Fig. 1. Alternative isoforms are encoded by the leo gene. (A) leo exons areleo II 14-3-3zeta-RA FBtr0088413 NM_165741
represented with boxes and introns with lines. The splicing pattern is indicated by14-3-3zeta-RB FBtr0088412 NM_165742
lines connecting the exons and the mutually exclusive exons 6, 6 and 6 are shaded
grey. The alternative 5 untranslated exons are indicated by hatched patterns, as is14-3-3zeta-RG FBtr0088417 NM_165745the untranslated portion of exon 7 bearing the three polyadenylation sites (open14-3-3zeta-RH FBtr0088418 NM_206070
circles). The relative locations of transposons ﬂanking exon 1 is shown by the14-3-3zeta-RI FBtr0100182 NM_0010114516
arrows, which indicate transcription of the bacterial lacZ reporter gene in (c) P2335leo III 14-3-3zeta-RC FBtr0088419 NM_165743 and (d) P1188 (black arrows) and the yeast gal4 transcription factor in (a) NP0863
(light grey) and (b) NP7346 (darker grey). (B) An alignment of the 54 predicted14-3-3zeta-RF FBtr0088416 NM_165744
amino acids encoded by the alternative exons differentiating LEOI, LEOII and LEOIII.
Position relative to the entire protein is denoted below the consensus. Conserved
residues are shaded in black and include the invariant sequence of amino acids 162-
184. Black arrows denote LEOIII-speciﬁc differences, open arrows LEOI-speciﬁc
differences, while the gray arrow denotes a highly variable position. (C) The identity
of the four Drosophila 14-3-3 isoforms within exon 6 with their closest human
homologs.2.3. Western blotting
Four heads were homogenized in 40 ll of lysis buffer (50 mM
Tris pH 7.5, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, contain-
ing protease and phosphatase inhibitors-Sigma). Sample equiva-
lence in total protein was conﬁrmed using the Quant-iT protein
assay (Molecular Probes). Laemmli buffer was added, samples
were boiled for 5 min at 92 C, centrifuged for 5 min at
14,000g, proteins were separated by SDS gel electrophoresis,
transferred on PVDF membrane and probed with rabbit anti-
LEO pAb [14] at 1:20,000 and anti-syntaxin mAb (8C3, DSHB) at
1:5000, followed by appropriate secondary HRP-conjugate Ab
(1:5000; Jackson ImmunoResearch) and visualized by
chemiluminescence.
2.4. Reverse transcription, qualitative and real-time PCR
RNA was prepared and qualitative PCR performed as before
[10], with typical annealing temperature 57 C. Quantitative PCR
Reactions were performed using the MiniOpticon System (Biorad),
with Platinum SYBR Green qPCR Supermix UDG (Invitrogen). Tran-
scripts of each leo isoform were ampliﬁed with the following pri-
mer sets:Forward Reverseleo I LeoCOM-177F LeoI- 465R
leo II LeoII- 461F LeoII- 565R
leo III LeoCOM-177F LeoIII-553RLeoCOM-177F: GTCATCGTGGCGTGTCATC, LeoI-465R: CCCTTG-
CTAATGTCAAAT, LeoII-461F: AGGCGTTCGATATTGCAAAAACC, Leo-II-565R: AGCCAATTGGCAAGCTTTGTC and LeoIII-553R: CCTCGCT-
GGTGAATTGAT.
act5C mRNA was ampliﬁed as internal standard. For each sam-
ple, leo and act5C were assayed in triplicate in separate wells and
monitored with the MJ Opticon Monitor Analysis software (v3.1)
and data quantiﬁed with the method described by Pfafﬂ and Hage-
leit [16]. Results presented are the average of three runs from two
independent reverse transcription reactions. Student’s t-tests were
used to probe the signiﬁcance of the differences between
RNAi-expressing strains and their respective controls. Multiple
comparisons using Tukey–Kramer HSD tests were utilized when
appropriate as indicated.
2.5. Immunocytochemistry in whole mount brains
Brains were dissected and ﬁxed for 20 min in 4% PFA in PBS.
Blocking was at room temperature for 1 h in 10% Normal Goat Ser-
um in PBHT (0.02 M PO4, 0.5 M NaCl, 0.2% Triton X-100, pH 7.4).
Anti-LEO pAb [14] was used (1:2000) over night at 4 C. After
washing, anti-rabbit IgG Alexa Fluor-conjugated (Molecular
Probes) secondary antibody was applied at 1:500 for minimally
4 h at room temperature, several washes were performed and sam-
ples were mounted in ﬂuorescent mounting medium (Dako). Con-
focal images were obtained with a Biorad Radiance 2100 system.
3. Results and discussion
The structure of leo transcripts and putative splicing pattern
according to Flybase’s annotated genomic sequence is shown in
Fig. 2. The ubiquitous LEOIII RNA encodes a functional isoform. (A) The distribution
of three predicted leomRNAs was investigated with qualitative RT–PCR. The tissues
sampled were: mid-development embryos (E), second instar larvae (L), mid-
pupation pupae (P) and from adult tissues, pooled thoraces (THX) of both sexes,
male (m) and female (f) abdomens (ABD) and pooled heads from both sexes (H). The
rp49 transcript was co-ampliﬁed with the leo mRNAs as a measure of reaction
success. (B) Rescue of the lethality of leoP1188 homozygotes (dark grey bars) and
heteroallelics with leoP2335 (light gray bars), by single isoforms-expressing trans-
genes expressed pan-neuronally. Rescue reﬂects the number of non-CyO progeny,
denoting leoP1188 homozygotes or leoP1188/leoP2335 heteroallelics recovered as a
percent of expected if the homozygotes (or heteroallelics) were fully viable.
Controls were derived by crossing with w1118. Asterisks indicate highly signiﬁcant
differences (P < 0.001 LSM contrast analysis) from controls (open bars), whereas #
indicate differences at P < 0.005. (C) Quantiﬁcation of the expression levels of the
isoform-speciﬁc transgenes in leoP1188 homozygotes relative to that of the endog-
enous actin5C. Identical primers for RT and PCR were used such that transcript
levels may be comparable. The mean ± its standard error (S.E.M.) is shown for three
independent experiments consisting of a triplicate determination for each ratio. The
level of LEOIII-speciﬁc transcript was signiﬁcantly different (Tukey–Kramer a = 0.01,
denoted by the asterisk) from the others.
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exon 6. The sixth exon encodes helices F and G in their entirety
and about half of helix H. The amino acid differences within the
alternative exons are summarized in Fig. 1B. There are two clusters
of distinct amino acids ﬂanking the invariant sequence (Supple-
mental Fig. 1), characteristic of helix G [4]. Differences at the ami-
no-terminal side are conﬁned within helix F and mostly distinguish
LEOI from LEOII [10]. The LEOII-speciﬁc amino-acids are also
shared by LEOIII, except for the conservative change Asp146 to
Glu, speciﬁc for LEOIII. A difference between LEOII and LEOIII is
at position 150, which is distinct in all three isoforms and in LEOIII
adds a second basic Lys in a row. However, LEOIII is most distinct
from the other two isoforms at the carboxy-terminal side of the
conserved block, where LEOI and LEOII do not differ. This region
forms the loop between helices G and H and thus is likely to affect
their spatial arrangement. Following the conservative Ile in place of
the typical Leu183, there is a drastic change from acidic Asp187 to
Ala, a conservative Lys188 to Arg and a Glut191 to His in LEOIII
(Fig. 1B). Thus, LEOIII differs by 10 amino acids from LEOI and 6
from LEOII. Because they are likely involved in ligand binding [5],
these differences are potentially functionally signiﬁcant. In fact, se-
quence alignment of the alternative exons of leo with the human
14-3-3s along their respective exon indicates LEOIII slightly (2%)
more similar with the b and c proteins rather than f (Fig. 1C).
To verify that exon 600 is indeed incorporated in leo transcripts,
we used an exon-speciﬁc reverse primer and a forward primer
within common exon 4, for oligo dT-initiated Reverse Transcrip-
tion coupled to the Polymerase Chain Reaction (RT–PCR) as de-
scribed previously [10]. In addition, to determine whether the
putative leolll RNA is expressed tissue-speciﬁcally, we used RNA
from different developmental stages and distinct adult tissues.
Bona ﬁde transcripts incorporating exon 600 were found in all Dro-
sophila life stages and tissues examined, as for leol and leoll
(Fig. 2A). In agreement with this conclusion, we identiﬁed a leolll
cDNA clone (out of 14 fully sequenced) in an adult head library
(data not shown). Furthermore, we obtained an independently iso-
lated leo cDNA clone [13] and upon sequencing we discovered it
represented the leolll transcript. Collectively, these data strongly
indicate that the Drosophila leo gene encodes three distinct protein
isoforms.
To address the question of whether LEOIII is a functional pro-
tein, we investigated the ability of UAS-leolll transgenes to reverse
the homozygous lethality associated with previously reported
[10,14], transposon mutations in the gene. We introduced the
UAS-leolll, UAS-leol and UAS-leoll transgenes in leoP1188/+ and
leoP2335/+ heterozygotes and determined the level of mutant homo-
zygotes recovered upon their pan-neuronal expression as de-
scribed previously [11]. All crosses were performed in triplicate,
the data were pooled and displayed in Fig. 2B. These results dem-
onstrate that pan-neuronal expression of UAS-leoIII resulted in
recovery of signiﬁcantly more leoP1188 homozygotes and leoP1188/
leoP2335 heteroallelics than obtained from control crosses and
UAS-leoI I was also effective in rescuing leoP1188 homozygotes
(Fig. 2B). Similar results were obtained with independent trans-
genes (not shown). To determine whether this difference resulted
from position-effect mediated variation in transgene expression,
we determined the relative transgene-speciﬁc RNA levels using
Quantitative RT–PCR (Q-RT–PCR). The results in Fig. 2C demon-
strate that although the relative levels of UAS-leoI and UAS-leoII
transcripts were similar, UAS-leoIII transcripts were actually less
abundant. Therefore, enhanced UAS-leoIII transgene expression
was probably not the reason for increased rescue from lethality
and unless LEOIII is more stable than the other isoforms, the differ-
ence likely underlies functional differences. Nonetheless, these re-
sults indicate that leoIII transcripts encode a functional LEO III
isoform.Are there differences in the tissue distribution of the three LEO
isoforms? The anti-LEO antibody recognizes all three isoforms as
expected (Supplemental Fig. 2), given that it is polyclonal, raised
against the entire protein [14] and the differences among the iso-
forms are small and non-contiguous. Therefore, we capitalized on
the availability of Gal4 drivers and transgenes able to abrogate
LEO levels by RNA-interference (RNAi). We drove such transgenes
with different tissue-speciﬁc Gal4 drivers and assessed the conse-
quences on the levels of each leo transcript using Q-RT–PCR. We
validated the assay using adult ﬂies null for leo. These animals
can be obtained as heteroallelics of leoP1188 with a novel lethal
insertion, leoNP7346 (Fig. 1A). Although leoNP7346, as leoP1188 homozy-
gotes are fully lethal, such heteroallelic animals can be obtained,
albeit relatively rarely, comprising 12–18% of the progeny of such
a cross. In agreement with prior results [10], these animals do
not exhibit external defects or grossly aberrant behaviors and ap-
pear devoid of LEO (Fig. 3A). As expected, Q-RT–PCR of RNA from
Fig. 3. Spatial distribution LEO isoforms. (A) A western blot of head lysates
demonstrating that leoP1188/leoNP7346 lack detectable LEO protein levels. Syntaxin
(SYX) was used as a loading control. (B) Quantitative RT–PCR of all three LEO
isoforms in adult heads of the protein null leoP1188/leoNP7346 animals with actin5C
internal reference. The leo/actin5C ratios were determined in triplicate for each
experiment and three such experiments using independently isolated RNA samples
were averaged and shown ± S.E.M. Paired Student’s t-tests indicated highly
signiﬁcant differences (P < 0.001) with the respective controls. (C) A western blot
of brain lysates from animals expressing leoRNAi under leoGal4 demonstrating the
reduction to near loss of LEO protein in that tissue. (D) Quantitative RT–PCR of RNA
isolated fromwhole heads of animals with LEO abrogated in the nervous system. All
experimental leo RNAs were signiﬁcantly different than those in controls (t-tests,
P < 0.001). (E) Whole mount confocal image stacks of anti-LEO immunohistochem-
istry in dissected brains of the indicated genotypes. Arrow points to the mushroom
body neurons, where LEO protein distributes preferentially in control animals and
the staining is absent in animals expressing the leoRNAi speciﬁcally in these
neurons. Arrowheads point to the ellipsoid body neuron somata where staining
remains in the later animals. (F) Quantitative RT–PCR of RNA isolated from heads of
animals with RNAi-abrogated LEO in the mushroom bodies. RNA levels of LEOIIIwas
signiﬁcantly different from respective controls (t-tests, P < 0.001), whereas those of
LEOI and LEOII were not (P = 0.09 and P = 0.27, respectively).
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transcripts compared to the respective relative levels in controls
(Fig. 3B).
14-3-3s are largely neuronal proteins, but also present in other
tissues [8,17] and LEO is also distributed widely [10]. Therefore, to
determine whether LEO isoforms may be distributed differentially
in Drosophila, we used RNAi-mediated abrogation to eliminate
them speciﬁcally within the adult nervous system using the pan-
neuronal ElavGal4 driver. Flies lacking LEO in the nervous system
were viable and did not exhibit obvious external defects. Western
blots from single dissected brains of such adults conﬁrmed the lack
of LEO in the nervous system (Fig. 3C). Samples for Q-RT–PCR wereprepared from entire heads (brain, head fat and muscles, cuticle
and external compound eye), to determine whether any of the
LEO isoforms was present outside the nervous system. The signals
for leoI and leoIII transcripts were highly diminished and near zero
in heads from such adults. However, although reduced compared
to controls, leoII-speciﬁc signal remained relatively elevated
(Fig. 3D). This is in contrast to the near elimination of the leoII-spe-
ciﬁc signal in the genetic nulls (Fig. 3B) and suggests that of the
three isoforms, LEOII is also present outside the nervous system
in adult heads.
LEO is preferentially distributed in the mushroom bodies [14],
neurons with critical roles in higher order behaviors including
learning and memory [18]. Therefore, to determine whether a
particular LEO isoform is preferentially present within the mush-
room bodies, we expressed the leoRNAi transgene with leoGal4
(see Section 2), a novel insertion in the gene (Fig. 1A), which ex-
presses Gal4 nearly exclusively within these neurons (Supple-
mental Fig. 2). Fig. 3E demonstrates lack of LEO within the
mushroom bodies upon leoRNAi expression with leoGal4. How-
ever, it remained unaltered in ellipsoid body neurons where
LEO is also abundant [10,14] and in the remainder of the brain,
attesting to the speciﬁcity of the driver. Q-RT–PCR of RNAs from
the heads of such animals indicated a prominent reduction for
leoIII, a smaller non-signiﬁcant reduction for leoI, whereas leoII
did not change appreciably (Fig. 3D). These results indicate that
LEOIII is preferentially distributed in mushroom body neurons.
LEOI and LEOII may also be marginally present within these neu-
rons. These results contrast our previous report [10] indicating
that LEOII was a mushroom body-speciﬁc isoform. Upon closer
examination, the leoII-‘‘speciﬁc” primer used in that study could
also hybridize to leoIII transcripts, because of the very low se-
quence divergence at the 5 of exons 6 and 6 where the primer
annealed. We posit then, that in these experiments the mush-
room body-preferential leoIII was abrogated by ablating these
neurons and it was reported erroneously as leoII because of the
sequence overlap and lack of information about leoIII.
Given the functional specialization of the mushroom bodies,
preferential distribution of LEOIII therein may also reﬂect func-
tional differences among the isoforms in these neurons consistent
with the sequence divergence within alternate sixth exons. The
preferential distribution of LEO isoforms at least in the adult Dro-
sophila head, indicates that alternative splicing of the distinct sixth
exons is not stochastic, but rather regulated, an event that may
even occur in other tissues and life stages.
Interestingly, vertebrate and especially mammalian species ap-
pear to employ multiple 14-3-3 proteins despite their unusually
high sequence identity, perhaps because small changes in relevant
amino acids result in signiﬁcant functional consequences. In con-
trast, the more compact Drosophila genome seems to have coped
with encoding this structurally small, but apparently functionally
signiﬁcant diversity by alternative splicing of a single transcript,
rather than multiple distinct 14-3-3 encoding genes. This appears
to have arisen by simple exon duplication and divergence, whereas
in the case of mammals entire gene(s) were likely duplicated and
diverged.
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